Louisiana Funds
VC Fund
Baton Rouge, United States
Louisiana Funds is an early stage venture capital fund focusing primarily on Louisiana-based life science companies. Louisiana Funds' portfolio includes pharmaceuticals, biotechnology, agritechnology, information technology, and other high technology firms.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 0%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Louisiana Funds invests in
Stages Louisiana Funds invests in
Countries Louisiana Funds invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Joseph Lovett
|
|||
Richard Babb
|
|||
Investment Focus
Industry
- Software 3 (27%)
- Health Care 3 (27%)
- Biotechnology 3 (27%)
- SaaS 1 (9%)
- Energy 1 (9%)
Stage
- Series A 4 (36%)
- Series B 3 (27%)
- Funding Round 2 (18%)
- Seed 1 (9%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Joseph Lovett
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
|
Richard Babb
Managing Director
|
Managing Director | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Qure4u
|
Qure4u is an all-in-one patient experience platform that offers a fully integrated solution that supports the entire patient journey. It drives brand equity, in-office efficiency, and revenue while enhancing clinical insight and improving the patient experience. It also empowers patients to prepare for appointments, monitor their vitals, andconnect with their providers via secure messaging and telehealth through Qure4u's all-in-one app.It was founded in 2011 and is headquartered in Bradenton, Florida. | $750K / Series A / Jul 06, 2018 | |
Omnidek
|
Omnidek is an enterprise smart data content management platform designed for companies of any size to build corporate forms, portals, workflows, and analytics in a single mobile/web platform. Omnidek offers an enterprise ecosystem to consolidate all third party application and simplify enterprise roll out of technology. | $950K / Seed / Jan 17, 2017 | |
Servato
|
Servato Cor develops Active Battery Management System (ABMS) which manages, monitors, and charges lead-acid batteries used for backup or reserve power in industrial settings. It provides a Platform-as-a-Service solution for remote DC power management in industrial settings. Utilizing an innovative new charging algorithm and management appliance andcloud-based visualization software, Servato provides unprecedented insight into and control over distributed DC power assets in a number of industries.The company was incorporated in 2014 and is based in New Orleans, Louisiana. | $3.9M / Aug 31, 2015 | |
Embera NeuroTherapeutics
|
Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brainfunctions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder. | $2.3M / Series A / Feb 26, 2015 | |
|
Embera NeuroTherapeutics
|
Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brainfunctions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder. | $4.5M / Series A / Aug 14, 2011 | |
Esperance Pharmaceuticals
|
Esperance Pharmaceuticals is developing a new class of targeted anticancer drugs that selectively kill cancer cells without harming normal cells. Targeting occurs through binding to specific receptors on the cell's surface. The drugs kill even those cells known to be resistant to chemotherapeutic drugs. | $7.5M / Series B / Jun 01, 2011 | |
|
Esperance Pharmaceuticals
|
Esperance Pharmaceuticals is developing a new class of targeted anticancer drugs that selectively kill cancer cells without harming normal cells. Targeting occurs through binding to specific receptors on the cell's surface. The drugs kill even those cells known to be resistant to chemotherapeutic drugs. | $3.2M / Series A / Nov 24, 2008 | |
Portico Learning Solutions
|
At Portico, they have focused on providing eLearning solutions to government and corporate entities since 1998. They specialize in courseware management and custom eLearning courseware development, and have implemented both their courseware and their learning management systems successfully in a wide range of technical environments. Their companycurrently provides eLearning to many companies spanning many industries, worldwide. Their approach to every solution is to match training initiatives to their clients' business objectives and strategies, enabling them to add value to their enterprise. | $1M / Mar 18, 2008 | |
Dowley Security Systems
|
Dowley Security Systems, Inc. provides electronic security and network integration solutions to critical infrastructure and commercial markets. It specializes in the design, installation, service, and support of security solutions for industrial, government, and commercial organizations. The company’s services include access control, intrusiondetection/monitoring, video surveillance, fire alarm and fire suppression, locksmithing, network infrastructure and integration, project management, service on-call, and budgeted maintenance. Dowley SecuSystems, Inc. was formerly known as Infrastruct Security, Inc. and changed its name to Dowley Security Systems, Inc. in April 2010. The company was founded in 1986 and is based in Houston, Texas with locations in Oklahoma City and Tulsa, Oklahoma. | $3M / Series B / Jun 28, 2007 | |
Flying Fish Creative Services
|
Flying Fish Creative Services is a commercial art studio. offering illustration, design, retouching, digital imaging, and photographic services. They focused on courseware management. They delivers creative solutions to small businesses, corporate clients and local non-profits. | $2.4M / Series B / Dec 08, 2006 | |
| See all 11 investments → | |||
Co-Investors
Advantage Capital
2 deals together
Enhanced Capital Partners
2 deals together
Louisiana Technology Innovation Fund
2 deals together
Atlanta Technology Angels
1 deal together
HRA Pharma
1 deal together
Innovation Catalyst
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Louisiana Funds invest in?
Louisiana Funds invests primarily in Software, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Louisiana Funds?
Public channels for Louisiana Funds include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Louisiana Funds?
The team at Louisiana Funds includes Joseph Lovett (Managing Director) and Richard Babb (Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
